393 results on '"Tailleux, Anne"'
Search Results
102. 171
103. Novel non-carboxylic acid retinoids: 1,2,4-Oxadiazol-5-one derivatives
104. Endogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formation
105. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model
106. Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits
107. Roles of PPARs in NAFLD: Potential therapeutic targets
108. Bone Marrow p16INK4a-Deficiency Does Not Modulate Obesity, Glucose Homeostasis or Atherosclerosis Development
109. PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH
110. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology
111. Peroxisome Proliferator–Activated Receptor-α Gene Level Differently Affects Lipid Metabolism and Inflammation in Apolipoprotein E2 Knock-In Mice
112. Overview of the Measurement of Lipids and Lipoproteins in Mice
113. Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia
114. Rexinoid Bexarotene Modulates Triglyceride but not Cholesterol Metabolism via Gene-Specific Permissivity of the RXR/LXR Heterodimer in the Liver
115. Morphologic and Electroretinographic Phenotype of SR-BI Knockout Mice after a Long-Term Atherogenic Diet
116. The RXR Agonist Bexarotene Improves Cholesterol Homeostasis and Inhibits Atherosclerosis Progression in a Mouse Model of Mixed Dyslipidemia
117. Niemann–Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine
118. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate
119. PPARα, but not PPARγ, Activators Decrease Macrophage-Laden Atherosclerotic Lesions in a Nondiabetic Mouse Model of Mixed Dyslipidemia
120. Increased Susceptibility of Low-Density Lipoprotein to Ex Vivo Oxidation in Mice Transgenic for Human Apolipoprotein B Treated with 1 Melatonin-Related Compound Is Not Associated with Atherosclerosis Progression
121. Apolipoprotein A-II, HDL metabolism and atherosclerosis
122. Lipid Free Apolipoprotein E Binds to the Class B Type I Scavenger Receptor I (SR-BI) and Enhances Cholesteryl Ester Uptake from Lipoproteins
123. Daily melatonin supplementation in mice increases atherosclerosis in proximal aorta
124. Improved Lipid and Lipoprotein Profile, Hepatic Insulin Sensitivity, and Glucose Tolerance in 11β-Hydroxysteroid Dehydrogenase Type 1 Null Mice
125. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia
126. Peroxisome Proliferator-activated Receptor α Is Not Rate-limiting for the Lipoprotein-lowering Action of Fish Oil
127. Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice
128. Paraoxonase Activity is Reduced by a Pro-atherosclerotic Diet in Rabbits
129. Cdkn2a/p16Ink4a Regulates Fasting-Induced Hepatic Gluconeogenesis Through the PKA-CREB-PGC1α Pathway.
130. Cholesterol Efflux, Lecithin−Cholesterol Acyltransferase Activity, and Pre-β Particle Formation by Serum from Human Apolipoprotein A-I and Apolipoprotein A-I/Apolipoprotein A-II Transgenic Mice Consistent with the Latter Being Less Effective for Reverse Cholesterol Transport
131. Transgenic Rabbits Expressing Human Apolipoprotein A-I in the Liver
132. Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic Rabbits
133. Tissue-specific Expression of the Human Gene for Lecithin: Cholesterol Acyltransferase in Transgenic Mice Alters Blood Lipids, Lipoproteins and Lipases towards a Less Atherogenic Profile
134. A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic mice
135. Prevention of in vitro low-density lipoprotein oxidation by an albumin-containing Lp A-I subfraction
136. Expression of apolipoprotein B epitopes in low density lipoproteins of hemodialyzed patients
137. Bone Marrow p16INK4a-Deficiency Does Not Modulate Obesity, Glucose Homeostasis or Atherosclerosis Development.
138. The hepatic compensatory response to elevated systemic sulfide promotes diabetes.
139. Endogenous cannabinoid receptor CB1activation promotes vascular smooth-muscle cell proliferation and neointima formation
140. p16INK4adeficiency promotes IL-4–induced polarization and inhibits proinflammatory signaling in macrophages
141. Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes
142. Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH.
143. AS138 - Alterations in bile acids and TGR5 activation in non-alcoholic steatohepatitis.
144. Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes.
145. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
146. Short Article Hypothalamic bile acid-TGR5 signaling protects from obesity
147. Sirt6 deletion in bone marrow-derived cells increases atherosclerosis - Central role of macrophage scavenger receptor 1
148. The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression
149. Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis.
150. PS1 - 2. Role of the tumour suppressor CDKN2A/p16INK4ain the development of perivascular adipose tissue
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.